Pages that link to "Q87397021"

The following pages link to Commercializing biomedical research through securitization techniques (Q87397021):

Displaying 10 items.

• The risks of risk aversion in drug regulation (Q38162718) (← links)
• Cancer megafunds with in silico and in vitro validation: accelerating cancer drug discovery via financial engineering without financial crisis (Q41884293) (← links)
• Alzheimer's disease drug development pipeline: 2017. (Q42655757) (← links)
• The cancer megafund: a catalyst for disruptive innovation (Q44779987) (← links)
• Just how good an investment is the biopharmaceutical sector? (Q47269158) (← links)
• The cancer megafund: mathematical modeling needed to gauge risk (Q51204098) (← links)
• Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets (Q60046512) (← links)
• The cancer megafund: determinants of success (Q86928549) (← links)
• Adaptive platform trials: definition, design, conduct and reporting considerations (Q92966010) (← links)
• A Brain Capital Grand Strategy: toward economic reimagination (Q100990214) (← links)